Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX)

Historical Holders from Q1 2019 to Q3 2024

Type / Class
Equity / Common Stock, par value $0.001 per share (the "Shares")
Symbol
FBRX on Nasdaq
Shares outstanding
6,500,794
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Farallon Capital Partners, L.P. 3.4% $12,130 221,027 Dapice Joshua J. 31 Dec 2024

Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2024 Q3 0 $0 -$10,134,239 0
2024 Q2 19,046,477 $10,228,138 -$6,914 $0.54 32
2024 Q1 19,048,634 $13,285,300 +$131,933 $0.70 32
2023 Q4 18,862,822 $15,499,549 +$107,364 $0.82 34
2023 Q3 16,699,691 $11,053,360 +$8,677,955 $0.66 30
2023 Q2 3,463,993 $3,601,147 -$405,929 $1.04 28
2023 Q1 3,865,337 $3,904,404 +$63,530 $1.01 28
2022 Q4 3,801,902 $3,800,654 -$331,796 $1.00 30
2022 Q3 2,668,691 $2,852,110 +$306,315 $1.07 24
2022 Q2 2,308,331 $3,001,130 -$1,978,602 $1.30 27
2022 Q1 3,886,365 $5,675,151 -$2,490,490 $1.46 44
2021 Q4 5,360,245 $11,473,214 +$2,615,294 $2.14 45
2021 Q3 3,861,588 $11,432,424 -$209,734,334 $2.96 52
2021 Q2 8,609,574 $289,376,415 +$20,624,459 $33.62 75
2021 Q1 7,968,324 $273,111,000 -$14,949,451 $34.27 62
2020 Q4 8,392,546 $305,570,000 +$56,276,590 $36.41 49
2020 Q3 6,803,921 $330,057,000 +$190,204,632 $48.51 45
2020 Q2 2,883,976 $42,049,000 +$42,049,000 $14.58 22
2020 Q1 66 $2,000 $30.30 1
2019 Q4 66 $2,000 $30.30 1
2019 Q3 66 $2,000 $30.30 1
2019 Q2 66 $2,000 $30.30 1
2019 Q1 66 $2,000 $30.30 1